BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25447484)

  • 21. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
    Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.
    Zhang F; Shao J; Tian J; Zhong Y; Ye L; Meng X; Liu Q; Wang H
    Sci Rep; 2016 Apr; 6():24233. PubMed ID: 27052887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
    Wang QS; Ding SL; Mao HP; Cui YL; Qi XJ
    J Ethnopharmacol; 2013 Jul; 148(2):603-9. PubMed ID: 23702040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse.
    Zhou XJ; Liu M; Yan JJ; Cao Y; Liu P
    J Ethnopharmacol; 2012 Jan; 139(2):422-8. PubMed ID: 22138350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).
    Liang Y; Shaw AM; Boules M; Briody S; Robinson J; Oliveros A; Blazar E; Williams K; Zhang Y; Carlier PR; Richelson E
    J Pharmacol Exp Ther; 2008 Nov; 327(2):573-83. PubMed ID: 18689611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties.
    Artaiz I; Zazpe A; Innerárity A; Del Olmo E; Díaz A; Ruiz-Ortega JA; Castro E; Pena R; Labeaga L; Pazos A; Orjales A
    Psychopharmacology (Berl); 2005 Nov; 182(3):400-13. PubMed ID: 16032410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system.
    Machado DG; Bettio LE; Cunha MP; Capra JC; Dalmarco JB; Pizzolatti MG; Rodrigues AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):642-50. PubMed ID: 19286446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant-like effect of gallic acid in mice: Dual involvement of serotonergic and catecholaminergic systems.
    Can ÖD; Turan N; Demir Özkay Ü; Öztürk Y
    Life Sci; 2017 Dec; 190():110-117. PubMed ID: 28942286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.
    Carter DS; Cai HY; Lee EK; Iyer PS; Lucas MC; Roetz R; Schoenfeld RC; Weikert RJ
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3941-5. PubMed ID: 20570146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system.
    Posser T; Kaster MP; Baraúna SC; Rocha JB; Rodrigues AL; Leal RB
    Eur J Pharmacol; 2009 Jan; 602(1):85-91. PubMed ID: 19026628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant-like effect of creatine in mice involves dopaminergic activation.
    Cunha MP; Machado DG; Capra JC; Jacinto J; Bettio LE; Rodrigues AL
    J Psychopharmacol; 2012 Nov; 26(11):1489-501. PubMed ID: 22674968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor.
    Xue R; Jin ZL; Chen HX; Yuan L; He XH; Zhang YP; Meng YG; Xu JP; Zheng JQ; Zhong BH; Li YF; Zhang YZ
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):728-41. PubMed ID: 22748419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.
    Skolnick P; Popik P; Janowsky A; Beer B; Lippa AS
    Eur J Pharmacol; 2003 Feb; 461(2-3):99-104. PubMed ID: 12586204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant-like effect of flavonoids extracted from Apocynum venetum leaves on brain monoamine levels and dopaminergic system.
    Zheng M; Fan Y; Shi D; Liu C
    J Ethnopharmacol; 2013 May; 147(1):108-13. PubMed ID: 23453939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system.
    Gay BM; Prigol M; Stein AL; Nogueira CW
    Neuropharmacology; 2010 Sep; 59(3):172-9. PubMed ID: 20488195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropharmacological and antidepressant-like effects of ZY-1408: A novel serotonin/norepinephrine reuptake inhibitor and serotonin receptor 2C antagonist.
    Gao N; Tiliwaerde M; Zheng W; Xiong J; Li X; Jin Z
    Neuropharmacology; 2021 Jan; 182():108376. PubMed ID: 33122031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of monoaminergic system in the antidepressant-like effect of (octylseleno)-xylofuranoside in the mouse tail suspension test.
    Pinto Brod LM; Fronza MG; Vargas JP; Lüdtke DS; Luchese C; Wilhelm EA; Savegnago L
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():201-7. PubMed ID: 26596986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents.
    Yamada K; Kobayashi M; Mori A; Jenner P; Kanda T
    Pharmacol Biochem Behav; 2013 Dec; 114-115():23-30. PubMed ID: 24201052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.